University of Arizona College of Medicine; Phoenix, Ariz.
Email: [email protected]
Author disclosure: No relevant financial relationships.
Editor's Note: This is the first complete update to guidelines for managing neonatal hyperbilirubinemia since 2004. Because kernicterus and bilirubin encephalopathy are exceedingly rare, the evidence behind this guideline is limited. The guideline committee included general pediatricians, a family physician, nurses, and breast-feeding experts, as well as experts in neonatal hyperbilirubinemia, which helped balance the priorities of minimizing separation of infants from their parents while protecting infants from the rare serious outcomes of hyperbilirubinemia. Although this guideline contains treatment nomograms, many clinicians use the calculator at https://www.bilitool.org instead, which has been updated with these new guidelines.—Steven R. Brown, MD, Contributing Editor
Dr. Brown was the AAFP representative to the 2022 Hyperbilirubinemia in Newborns: Updated Guidelines from the American Academy of Pediatrics clinical practice guideline committee.
